Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hospital kids get better sleep when night vitals are skipped, study hints

NCT ID NCT06865781

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether not taking vital signs (like temperature and heart rate) at midnight and 4 a.m. helps children in the hospital sleep longer and better. Researchers are comparing 160 children who either skip those checks or get standard care. The goal is to see if reducing nighttime disruptions improves sleep without compromising safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
forgoing overnight vital signs
What this could lead to
If it works, this could lead to better sleep for children in the hospital without harming their safety.
What could go wrong
This is a small, early study. Skipping vital signs might miss early warning signs of a child getting worse, and results may not apply to all hospitals or sicker children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Nov 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 year to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hospitalized at Primary Children's Hospital on units 3 Southeast, 3 Northeast, 3 Northwest * Age 1-18 years * Pediatric Early Warning Score ≤ 1 at 2000 * A parent/home caregiver present to consent to study * Patient and home caregiver speak English or Spanish. * Deemed appropriate for forgone overnight vital signs by care team (attending MD/Advanced Practice Provider and bedside RN). Exclusion Criteria: * Pre-existing diagnosis of hypertension, kidney disease, pulmonary hypertension, chronic lung disease, congenital heart disease causing cardiopulmonary compromise, obstructive sleep apnea, seizure disorder, neuromuscular disability. * Patients requiring O2 monitoring at home. * The following medications in the previous 24 hours: opioids, intravenous immunoglobulin, intravenous magnesium, continuous albuterol, benzodiazepines, other sedating medications beyond home regimen. * Anaphylaxis within 24 hours * Within the first 24 hours post-operative period * Requiring oxygen above baseline * Fever in the last 24 hours. * Sepsis alert in the last 72 hours.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hospitalization are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Intermountain Primary Children's Hospital

    Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.